Children are routinely exposed to adverts for weight loss injections and pills online, according to a report by the ...

Novo's lawsuit comes less than one week after Hims & Hers announced plans to sell a compounded version of Novo's weight-loss ...

People taking GLP-1 weight loss drugs could be at risk of an ages-old disease, a new study has warned. New research has highlighted an unexpected potential health impact of weight loss drugs such as ...

Those looking to lose weight, could get some financial help from Hawaii lawmakers. A proposed measure at the State Capitol ...

Lilly's GLP-1 drugs continue to be the company's biggest growth driver. In Q4, sales of Mounjaro surged 110% to $7.4 billion, ...

The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.

The first was motivated by the hope that weight-loss drugs could pay for themselves. Obesity is expensive, as it raises the ...

On any given morning in Mumbai’s Shivaji Park, power-walkers circle the running track, fitness watches buzzing with every step. Minutes later, some drift toward nearby food stalls, where oil sizzles ...

Independent of FDA’s enhanced oversight, it’s clear that DTC promotion of weight loss drugs is having a moment, as companies go all in in pursuit of uptake expansion.

Why People Won’t Quit a Weight Loss Drug – Even When It Makes Them Feel Sick Patients who use semaglutide for weight loss, ...

Hims & Hers said it would stop selling its new compounded semaglutide pill after "constructive conversations with ...

And last month, Serena said that her life has changed “for the better” since she started using the medication, noting that it ...